Q4 2024 Earnings Call Transcript March 12, 2025 OptimizeRx Corporation beats earnings expectations. Reported EPS is $0.3, ...

OptimizeRx reports sales of $32.32M in Q4, beating consensus, with adjusted EPS of $0.30. Full-year revenue increased 29% and ...

Stephen Silvestro; President, Chief Executive Officer; OPTIMIZERx Corp. Edward Stelmakh; Chief Financial Officer, Chief Operating Officer; OPTIMIZERx Corp. Andrew D' ...

Full Year 2024 Results Key Financial Results Revenue: US$92.1m (up 29% from FY 2023).

OptimizeRx (OPRX) delivered earnings and revenue surprises of 20% and 9.58%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Q4 revenue of $32.3 million, increasing 14% year-over-yearQ4 gross profit increased 23% year-over-year to $22.0 million with gross margin of ...

Reports Q4 revenue $32.317M, consensus $30.36M. Stephen Silvestro, OptimizeRx (OPRX) CEO commented, “I’m incredibly proud of our strong fourth ...

Q4 2024 Results Conference Call March 12, 2025 8:30 AM ETCompany ParticipantsSteve Silvestro - PresidentEdward ...

OptimizeRx (NASDAQ:OPRX – Get Free Report) will likely be posting its quarterly earnings results before the market opens on Wednesday, March 12th. Analysts expect OptimizeRx to post earnings of $0.25 ...

This article was originally published on Quiver News, read the full story. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of ...

OptimizeRx Corp. (OPRX) came out with quarterly earnings of $0.30 per share, beating the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.26 per share a year ago.